Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Select your species
variable transposon epigenetic silencing underlies the variable mef2ca mutant bone phenotype, and could be a widespread mechanism of phenotypic variability in animals.
Mef2 (zeige MYEF2 ELISA Kits) controls skeletal muscle formation after terminal differentiation.
Our study provides new insights in MEF2C conservation and provides the first evidence of mef2cb regulation by both transcriptional and post transcriptional mechanisms.
By selectively inhibiting translational initiation of mef2ca and other mRNAs, eIF4EBP3L reprograms the translational profile of muscle, enabling it to adjust to new environmental conditions.
find no evidence that the phenotypic stability in the wild type is provided by redundancy between mef2ca and its co-ortholog mef2cb, or that it is related to the selector (homeotic) gene function of mef2ca
Mef2ca single mutants have delayed heart development, but form an apparently normal heart. Mef2cb single mutants have a functional heart and are viable adults.
Data show that mef2cb is expressed in the late ventricular region, and is necessary for late myocardial addition to the arterial pole.
the genetic interaction of Tbx5 (zeige TBX5 ELISA Kits) and Mef2c is not only required for MYH6 (zeige MYH6 ELISA Kits) expression but also essential for the early stages of heart development and survival
Mef2c and Mef2d (zeige MEF2D ELISA Kits) are required for proper cardiac gene expression.
a MEF2C and CEBPA correlation in CML disease progression
Single nucleotide polymorphism in MEF2C gene is associated with major depressive disorder.
we identified novel associations in WLS (zeige WLS ELISA Kits) , ARHGAP1 (zeige ARHGAP1 ELISA Kits) , and 5' of MEF2C ( P- values < 8x10 - 5 ; false discovery rate (FDR) q-values < 0.01) that were much more strongly associated with BMD (zeige BEST1 ELISA Kits) compared to the GWAS SNPs.
Our analysis consistently identified significant sub-networks associated with the interacting transcription factors MEF2C and TWIST1 (zeige TWIST1 ELISA Kits), genes not previously associated with spontaneous preterm births , both of which regulate processes clearly relevant to birth timing.
Key role for miR (zeige MLXIP ELISA Kits)-214 in modulation of MEF2C-MYOCD (zeige MYOCD ELISA Kits)-LMOD1 (zeige LMOD1 ELISA Kits) signaling.
Endothelial Mef2c regulates the endothelial actin cytoskeleton and inhibits smooth muscle cell migration into the intima.
The mRNA expressions of PPP3CB (zeige PPP3CB ELISA Kits) and MEF2C were significantly up-regulated, and CAMK1 (zeige CAMK1 ELISA Kits) and PPP3R1 (zeige PPP3R1 ELISA Kits) were significantly down-regulated in mitral regurgitation(MR) patients compared to normal subjects. Moreover, MR patients had significantly increased mRNA levels of PPP3CB (zeige PPP3CB ELISA Kits), MEF2C and PLCE1 (zeige PLCE1 ELISA Kits) compared to aortic valve disease patients
Findings suggest that a single introduction of the three cardiomyogenic transcription factor (GATA4 (zeige GATA4 ELISA Kits), cand TBX5 (zeige TBX5 ELISA Kits))genes using polyethyleneimine (PEI)-based transfection is sufficient for transdifferentiation of adipose-derived stem cells (hADSCs) towards the cardiomyogenic lineage.
Mef2c is highly expressed in the retina where it modulates photoreceptor-specific gene expression
Study provides evidence that Mef2c cooperated with Sp1 (zeige PSG1 ELISA Kits) to activate human AQP1 (zeige AQP1 ELISA Kits) transcription by binding to its proximal promoter in human umbilical cord vein endothelial cells indicating that AQP1 (zeige AQP1 ELISA Kits) is a direct target of Mef2c in regulating angiogenesis and vasculogenesis of endothelial cells.
Deletion and mutation analyses of the promoter of pig myocyte enhancer factor 2 (MEF2 (zeige MYEF2 ELISA Kits)) gene showed that MyoD (zeige MYOD1 ELISA Kits) and MEF2 (zeige MYEF2 ELISA Kits) binding sites within the Mef2c promoter were responsible for the regulation of Mef2c transcription. This study helped to clarify the regulation of Mef2c in muscle differentiation and regeneration.
The cDNA sequence was analyzed and the 5' upstream region of the mef2c gene was isolated from porcine genomic DNA.
analysis of sequence and variations of the bovine myocyte enhancer factor 2C (MEF2C) gene promoter in Bos taurus cattle
Here, the authors show that loss of Fxn (zeige FXN ELISA Kits) in the nervous system in mice also activates an iron/sphingolipid/PDK1 (zeige PDPK1 ELISA Kits)/Mef2 pathway, indicating that the mechanism is evolutionarily conserved.
Ca(2 (zeige CA2 ELISA Kits)+) signaling pathway increases Nr4a1 (zeige NR4A1 ELISA Kits) expression in MA-10 Leydig cells, at least in part, by enhancing the recruitment of coactivator most likely through the MEF2, AP1 (zeige JUN ELISA Kits), and CREB (zeige CREB1 ELISA Kits) transcription factors thus demonstrating an important interplay between the Ca(2 (zeige CA2 ELISA Kits)+) and cAMP pathways in regulating Nr4a1 (zeige NR4A1 ELISA Kits) expression.
HDAC5 (zeige HDAC5 ELISA Kits) emerges as a cellular conductor of MEF2C and M6a (zeige GPM6A ELISA Kits) activity and is regulated by miR (zeige MLXIP ELISA Kits)-124 and miR (zeige MLXIP ELISA Kits)-9 to control neurite development.
In cardiomyocytes exposed to biomechanical stimulation, FAK (zeige PTK2 ELISA Kits) accumulates in the nucleus, binds to and upregulates the transcriptional activity of MEF2c through an interaction with the FAK (zeige PTK2 ELISA Kits) focal adhesion targeting (FAT) domain.
In Fmr1 (zeige FMR1 ELISA Kits) KO neurons, Mdm2 (zeige MDM2 ELISA Kits) is hyperphosphorylated, nuclear localized basally, and unaffected by MEF2 activation, which our data suggest due to an enhanced interaction with Eukaryotic Elongation Factor (zeige TSFM ELISA Kits) 1alpha (EF1alpha), whose protein levels are elevated in Fmr1 (zeige FMR1 ELISA Kits) KO. Expression of a dephosphomimetic of Mdm2 (zeige MDM2 ELISA Kits) rescues PSD-95 (zeige DLG4 ELISA Kits) ubiquitination, degradation and synapse elimination in Fmr1 (zeige FMR1 ELISA Kits) KO neurons.
two MEF2 sites in the enhancer function cooperatively due to bridging of the MEF2C-bound sites by the SAP (zeige APCS ELISA Kits) domain-containing co-activator protein myocardin (zeige MYOCD ELISA Kits)
Our results elucidate the specific role of the transcription factors CREB (zeige CREB1 ELISA Kits), SRF, and MEF2 in the depression and potentiation components of ODP in vivo, therefore better informing future attempts to find therapeutic targets for diseases where activity-dependent plasticity is disrupted.
that Foxp2 (zeige FOXP2 ELISA Kits)-Mef2C signaling is critical to corticostriatal circuit formation
Postnatal, postsynaptic deletion of Mef2c in a sparse population of L2/3 neurons suppressed development of excitatory synaptic connections from all local input pathways tested. In the same cell population, Mef2c deletion promoted the strength of excitatory inputs originating from contralateral neocortex. Both the synapse promoting and synapse suppressing effects of Mef2c deletion required normal whisking experience.
Critical role for MEF2C in the regulation of spine numbers with a dissociation of learning and memory, synaptic plasticity, and measures of autism-related behaviors in postnatal mouse brain.
This locus encodes a member of the MADS box transcription enhancer factor 2 (MEF2) family of proteins, which play a role in myogenesis. The encoded protein, MEF2 polypeptide C, has both trans-activating and DNA binding activities. This protein may play a role in maintaining the differentiated state of muscle cells. Mutations and deletions at this locus have been associated with severe mental retardation, stereotypic movements, epilepsy, and cerebral malformation. Alternatively spliced transcript variants have been described.
myocyte-specific enhancer factor 2C
, myocyte enhancer factor 2C
, myocyte-specific enhancer factor 2C-like
, MADS box transcription enhancer factor 2, polypeptide C
, MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)
, Myocyte enhancer factor 2C protein
, myocyte enhancer factor 2c